The association between CDKL3 and tumor progression was clearly indicated by the CDKL3 upregulation in prostate cancer tissues and its correlation with Gleason score and tumor stage, both of which are important characteristics of prostate cancer. This evidence concerns the gene CDKL3 and prostate cancer.